Sensory symptoms across the lifespan in people with cerebral palsy

Ariel M Lyons-Warren; Danielle Guez-Barber; Sruthi P. Thomas; Evelyne K Tantry; Aditya Mahat; Bhooma Aravamuthan; Cerebral Palsy Research Network

doi:10.1101/2023.07.21.23292955

Structured Abstract

AIM To estimate prevalence of sensory symptoms in people with cerebral palsy (CP) across the lifespan.

METHOD In this cross-sectional study, the self-reported Sensory Processing Scale Inventory (SPS-I) was administered via REDCap between 2/1/22 and 8/15/22 to people with CP or their caregivers enrolled in the online MyCP Community Registry. We determined the association between SPS-I scores and age (Pearson correlation) and functional status as assessed using five validated functional classification systems for CP (ANOVA). We hypothesized that sensory symptoms would differ between younger and older individuals with CP.

RESULTS Of 155 responses (28% response rate, age 1-76 years, 34% male), 97% reported at least one bothersome sensory symptom. Total sensory symptoms decreased with age (R²=0.12, p<0.0001), driven by decreases in hyposensitivity symptoms (R²=0.32, p<0.0001), primarily tactile hyposensitivity (R²=0.29, p<0.0001). Sensory symptoms increased with greater functional impairment across all functional domains (ANOVA, p<0.0001). However, the age-specific decrease in hypo-sensitivities was most pronounced in people with the greatest gross motor functional impairment (R²=0.70, p=0.0004).

INTERPRETATION Our findings suggest that hypo-sensitivity, primarily tactile sensitivity, decreases with age in people with CP. Future work should assess whether decreased hyposensitivity contributes to other age-related changes in CP like increased pain.

What this paper adds

Individuals with CP exhibit both hyper- and hypo-sensitivity across all sensory modalities
Hyposensitivity decreases with age in people with CP, independent of GMFCS level
Less hyposensitivity correlates with greater functional ability in people with CP
Of all sensory modalities, tactile hyposensitivity correlates most strongly with age.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

NINDS 1K08NS117850-01A1 (BRA)

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This cross-sectional survey study received a human subject research exemption from the Washington University Institutional Review Board (IRB Identification Number: 201908233).

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes